<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334847</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1081</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14091081</ELocationID><Abstract><AbstractText>Long-lasting COVID-19 (long COVID) diseases constitute a real life-changing burden for many patients around the globe and, overall, can be considered societal and economic issues. They include a variety of symptoms, such as fatigue, loss of smell (anosmia), and neurological-cognitive sequelae, such as memory loss, anxiety, brain fog, acute encephalitis, and stroke, collectively called long neuro-COVID-19 (long neuro-COVID). They also include cardiopulmonary sequelae, such as myocardial infarction, pulmonary damage, fibrosis, gastrointestinal dysregulation, renal failure, and vascular endothelial dysregulation, and the onset of new diabetes, with each symptom usually being treated individually. The main unmet challenge is to understand the mechanisms of the pathophysiologic sequelae, in particular the neurological symptoms. This mini-review presents the main mechanistic hypotheses considered to explain the multiple long neuro-COVID symptoms, namely immune dysregulation and prolonged inflammation, persistent viral reservoirs, vascular and endothelial dysfunction, and the disruption of the neurotransmitter signaling along various paths. We suggest that the nucleoprotein N of SARS-CoV-2 constitutes a "hub" between the virus and the host inflammation, immunity, and neurotransmission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Slama Schwok</LastName><ForeName>Anny</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2703-9728</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, INSERM U938, Biology and Cancer Therapeutics, Centre de Recherche Saint Antoine, Saint Antoine Hospital, 75231 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henri</LastName><ForeName>Julien</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0772-8881</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, CNRS UMR 7238, Laboratoire de Biologie Computationnelle et Quantitative, Institut de Biologie Paris-Seine, 75005 Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COVNUCLEOVIR</GrantID><Agency>Sorbonne Universit&#xe9;</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">enkephalin</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">neurotransmission</Keyword><Keyword MajorTopicYN="N">nucleoprotein</Keyword><Keyword MajorTopicYN="N">substance P</Keyword><Keyword MajorTopicYN="N">viral reservoirs</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334847</ArticleId><ArticleId IdType="pmc">PMC11429791</ArticleId><ArticleId IdType="doi">10.3390/biom14091081</ArticleId><ArticleId IdType="pii">biom14091081</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khullar D., Zhang Y., Zang C., Xu Z., Wang F., Weiner M.G., Carton T.W., Rothman R.L., Block J.P., Kaushal R. Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: An EHR-Based Cohort Study from the RECOVER Program. J. Gen. Intern. Med. 2023;38:1127&#x2013;1136. doi: 10.1007/s11606-022-07997-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07997-1</ArticleId><ArticleId IdType="pmc">PMC9933823</ArticleId><ArticleId IdType="pubmed">36795327</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang C., Hou Y., Schenck E., Xu Z., Zhang Y., Xu J., Bian J., Morozyuk D., Khullar D., Nordvig A., et al. Risk Factors and Predictive Modeling for Post-Acute Sequelae of SARS-CoV-2 Infection: Findings from EHR Cohorts of the RECOVER Initiative. Commun. Med. 2024;4 doi: 10.1038/s43856-024-00549-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-024-00549-0</ArticleId><ArticleId IdType="pmc">PMC11239808</ArticleId><ArticleId IdType="pubmed">38992068</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang C., Hou Y., Schenck E.J., Xu Z., Zhang Y., Xu J., Bian J., Morozyuk D., Khullar D., Nordvig A.S., et al. Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts. Commun. Med. 2024;4:130. doi: 10.1038/s43856-024-00549-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-024-00549-0</ArticleId><ArticleId IdType="pmc">PMC11239808</ArticleId><ArticleId IdType="pubmed">38992068</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Laracy J.C., Kamboj M., Vardhana S.A. Long and persistent COVID-19 in patients with hematologic malignancies: From bench to bedside. Curr. Opin. Infect. Dis. 2022;35:271&#x2013;279. doi: 10.1097/QCO.0000000000000841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000841</ArticleId><ArticleId IdType="pmc">PMC9922441</ArticleId><ArticleId IdType="pubmed">35849516</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deitchman A.N., Torres L., Iyer N.S., Munter S.E., Nixon C.C., Donatelli J., Thanh C., Takahashi S., Hakim J., et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36:109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Henri J., Minder L., Mohanasundaram K., Dilly S., Goupil-Lamy A., Di Primo C., Schwok A.S. Neuropeptides, New Ligands of SARS-CoV-2 Nucleoprotein, a Potential Link between Replication, Inflammation and Neurotransmission. Molecules. 2022;27:8094. doi: 10.3390/molecules27228094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27228094</ArticleId><ArticleId IdType="pmc">PMC9698730</ArticleId><ArticleId IdType="pubmed">36432196</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson B.A., Visvabharathy L., Ali S.T., Kang A.K., Patel T.R., Clark J.R., Lim P.H., Orban Z.S., Hwang S.S., Mattoon D., et al. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1151. doi: 10.1212/NXI.0000000000001151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Hanson B.A., Orban Z.S., Lim P.H., Palacio N.M., Jimenez M., Clark J.R., Graham E.L., Liotta E.M., Tachas G., et al. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front. Immunol. 2023;14:1155770. doi: 10.3389/fimmu.2023.1155770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId><ArticleId IdType="pmc">PMC10258318</ArticleId><ArticleId IdType="pubmed">37313412</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T., Varnai R., Schranz D., Zavori L., Peterfi Z., Sipos D., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Buki A., Csecsei P. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. J. Clin. Med. 2021;10:4337. doi: 10.3390/jcm10194337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Varnai R., Molnar T., Zavori L., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Kanizsai A., Csecsei P. Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms. Vaccines. 2022;10:165. doi: 10.3390/vaccines10020165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020165</ArticleId><ArticleId IdType="pmc">PMC8924883</ArticleId><ArticleId IdType="pubmed">35214624</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher J., Bean C., Zangrandi L., Kmiec I., Agostinho A., Scorrano L., Gnaiger E., Schwarzer C. Proenkephalin Derived Peptides Are Involved in the Modulation of Mitochondrial Respiratory Control During Epileptogenesis. Front. Mol. Neurosci. 2018;11:351. doi: 10.3389/fnmol.2018.00351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00351</ArticleId><ArticleId IdType="pmc">PMC6167428</ArticleId><ArticleId IdType="pubmed">30319356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury B., Sahoo B.M., Jena A.P., Hiramani K., Behera A., Acharya B. NOX-2 Inhibitors may be Potential Drug Candidates for the Management of COVID-19 Complications. Curr. Drug Res. Rev. 2024;16:128&#x2013;133. doi: 10.2174/2589977515666230706114812.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2589977515666230706114812</ArticleId><ArticleId IdType="pubmed">37415374</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo J., Bellot G., Pervaiz S., Alonso S. Mitochondria-mediated oxidative stress during viral infection. Trends Microbiol. 2022;30:679&#x2013;692. doi: 10.1016/j.tim.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2021.12.011</ArticleId><ArticleId IdType="pubmed">35063304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L., Shi M., Ma J., Shao S., Yuan Y., Liu J., Yu Z., Zhang Z., H&#xf6;lscher C. A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice. J. Prev. Alzheimer&#x2019;s Dis. 2024;11:382&#x2013;401. doi: 10.14283/jpad.2024.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2024.6</ArticleId><ArticleId IdType="pubmed">38374745</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeney M.T., Hoffman E.K., Farmer K., Bodle C.R., Fazzari M., Zharikov A., Castro S.L., Hu X., Mortimer A., Kofler J.K., et al. NADPH oxidase 2 activity in Parkinson&#x2019;s disease. Neurobiol. Dis. 2022;170:105754. doi: 10.1016/j.nbd.2022.105754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105754</ArticleId><ArticleId IdType="pmc">PMC9284948</ArticleId><ArticleId IdType="pubmed">35577065</ArticleId></ArticleIdList></Reference><Reference><Citation>Pileggi C.A., Parmar G., Elkhatib H., Stewart C.M., Alecu I., C&#xf4;t&#xe9; M., Bennett S.A., Sandhu J.K., Cuperlovic-Culf M., Harper M.-E. The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics. Curr. Res. Neurobiol. 2023;5:100112. doi: 10.1016/j.crneur.2023.100112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crneur.2023.100112</ArticleId><ArticleId IdType="pmc">PMC10663135</ArticleId><ArticleId IdType="pubmed">38020812</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., B&#xfc;ttiker P., Weissenberger S., Martin A., Ptacek R., Kream R.M. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis. Med Sci. Monit. 2021;27:e933015. doi: 10.12659/MSM.933015.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.933015</ArticleId><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Yang L., Han Z., Zhou X., Zhang Z., Sun T., Zheng F., Yang J., Guan F., Xie J., et al. SARS-CoV-2 nucleocapsid protein enhances the level of mitochondrial reactive oxygen species. J. Med Virol. 2023;95:e29270. doi: 10.1002/jmv.29270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29270</ArticleId><ArticleId IdType="pubmed">38047459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., RECOVER Mechanistic Pathways Task Force Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19&#x2013;related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo G.D., Perraud V., Alvarez F., Vieites-Prado A., Kim S., Kergoat L., Coleon A., Tr&#xfc;eb B.S., Tichit M., Piazza A., et al. Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants. Nat. Commun. 2023;14:4485. doi: 10.1038/s41467-023-40228-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40228-7</ArticleId><ArticleId IdType="pmc">PMC10372078</ArticleId><ArticleId IdType="pubmed">37495586</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B., RECOVER Mechanistic Pathway Task Force Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) eLife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Janket S.-J., Fraser D.D., E Baird A., Tamimi F., Sohaei D., A Conte H., Prassas I., Diamandis E.P. Tachykinins and the potential causal factors for post-COVID-19 condition. Lancet Microbe. 2023;4:e642&#x2013;e650. doi: 10.1016/S2666-5247(23)00111-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00111-8</ArticleId><ArticleId IdType="pmc">PMC10263974</ArticleId><ArticleId IdType="pubmed">37327802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritano D., Mastrangelo F., D&#x2019;ovidio C., Ronconi G., Caraffa A., Gallenga C.E., Frydas I., Kritas S.K., Trimarchi M., Carinci F., et al. Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines. Int. J. Mol. Sci. 2023;24:4811. doi: 10.3390/ijms24054811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054811</ArticleId><ArticleId IdType="pmc">PMC10002992</ArticleId><ArticleId IdType="pubmed">36902240</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehboob R., Kurdi M., Bamaga A., Aldardeir N., Nasief H., Moshref L.H., Alsinani T., Rayes A.O., Jabbad R.H. Substance P/Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link? Front. Med. 2021;8:727593. doi: 10.3389/fmed.2021.727593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.727593</ArticleId><ArticleId IdType="pmc">PMC8637107</ArticleId><ArticleId IdType="pubmed">34869423</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson G., Carbone A., Mazzoccoli G. Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress. Biology. 2020;9:249. doi: 10.3390/biology9090249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology9090249</ArticleId><ArticleId IdType="pmc">PMC7564943</ArticleId><ArticleId IdType="pubmed">32867244</ArticleId></ArticleIdList></Reference><Reference><Citation>Turski W.A., Wnorowski A., Turski G.N., Turski C.A., Turski L. AhR and IDO1 in pathogenesis of COVID-19 and the &#x201c;Systemic AhR Activation Syndrome:&#x201d; a translational review and therapeutic perspectives. Restor. Neurol. Neurosci. 2020;38:343&#x2013;354. doi: 10.3233/RNN-201042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-201042</ArticleId><ArticleId IdType="pmc">PMC7592680</ArticleId><ArticleId IdType="pubmed">32597823</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Du T., Wang J., Tang C., Lei M., Yu W., Yang Y., Ma Y., Huang P., Chen H., et al. Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target. Sci. Adv. 2023;9:eadf0211. doi: 10.1126/sciadv.adf0211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adf0211</ArticleId><ArticleId IdType="pmc">PMC10413656</ArticleId><ArticleId IdType="pubmed">37256962</ArticleId></ArticleIdList></Reference><Reference><Citation>Amici C., Di Caro A., Ciucci A., Chiappa L., Castilletti C., Martella V., Decaro N., Buonavoglia C., Capobianchi M.R., Santoro M.G. Indomethacin Has a Potent Antiviral Activity against Sars Coronavirus. Antivir. Ther. 2006;11:1021&#x2013;1030. doi: 10.1177/135965350601100803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/135965350601100803</ArticleId><ArticleId IdType="pubmed">17302372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lejal N., Tarus B., Bouguyon E., Chenavas S., Bertho N., Delmas B., Ruigrok R.W.H., Di Primo C., Slama-Schwok A. Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A Virus. Antimicrob. Agents Chemother. 2013;57:2231&#x2013;2242. doi: 10.1128/AAC.02335-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02335-12</ArticleId><ArticleId IdType="pmc">PMC3632891</ArticleId><ArticleId IdType="pubmed">23459490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravichandran R., Mohan S.K., Sukumaran S.K., Kamaraj D., Daivasuga S.S., Ravi S.O.A.S., Vijayaraghavalu S., Kumar R.K. An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised COVID-19 patients. Sci. Rep. 2022;12:6413. doi: 10.1038/s41598-022-10370-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10370-1</ArticleId><ArticleId IdType="pmc">PMC9016692</ArticleId><ArticleId IdType="pubmed">35440611</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrier O., Dilly S., Pizzorno A., Chalupska D., Humpolickova J., Bou&#x159;a E., Berenbaum F., Quideau S., Lina B., F&#xe8;ve B., et al. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus. Molecules. 2021;26:2593. doi: 10.3390/molecules26092593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26092593</ArticleId><ArticleId IdType="pmc">PMC8124269</ArticleId><ArticleId IdType="pubmed">33946802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrlich A., Ioannidis K., Nasar M., Abu Alkian I., Daskal Y., Atari N., Kliker L., Rainy N., Hofree M., Tikva S.S., et al. Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: In vitro, observational, and non-randomized open-label interventional study. eLife. 2023;12:e79946. doi: 10.7554/eLife.79946.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.79946</ArticleId><ArticleId IdType="pmc">PMC9937660</ArticleId><ArticleId IdType="pubmed">36705566</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Tan H.-E., Lu Z., Tsang K.S., Chung A.J., Zuker C.S. Gut&#x2013;brain circuits for fat preference. Nature. 2022;610:722&#x2013;730. doi: 10.1038/s41586-022-05266-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05266-z</ArticleId><ArticleId IdType="pmc">PMC9605869</ArticleId><ArticleId IdType="pubmed">36070796</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y., Lei T., Patel P.S., Lee C.H., Monaghan-Nichols P., Xin H.-B., Qiu J., Fu M. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J. Virol. 2021;95:e0139621. doi: 10.1128/JVI.01396-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01396-21</ArticleId><ArticleId IdType="pmc">PMC8577385</ArticleId><ArticleId IdType="pubmed">34549987</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H.-E., Sisti A.C., Jin H., Vignovich M., Villavicencio M., Tsang K.S., Goffer Y., Zuker C.S. The gut&#x2013;brain axis mediates sugar preference. Nature. 2020;580:511&#x2013;516. doi: 10.1038/s41586-020-2199-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2199-7</ArticleId><ArticleId IdType="pmc">PMC7185044</ArticleId><ArticleId IdType="pubmed">32322067</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikura T., Nakano T., Kitano T., Tokuda T., Sumi-Akamaru H., Naka T. Serum ferritin level during hospitalization is associated with Brain Fog after COVID-19. Sci. Rep. 2023;13:13095. doi: 10.1038/s41598-023-40011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-40011-0</ArticleId><ArticleId IdType="pmc">PMC10421912</ArticleId><ArticleId IdType="pubmed">37567939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronstein-Wiedemann R., Stadtm&#xfc;ller M., Traikov S., Georgi M., Teichert M., Yosef H., Wallenborn J., Karl A., Sch&#xfc;tze K., Wagner M., et al. SARS-CoV-2 Infects Red Blood Cell Progenitors and Dysregulates Hemoglobin and Iron Metabolism. Stem Cell Rev. Rep. 2022;18:1809&#x2013;1821. doi: 10.1007/s12015-021-10322-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-021-10322-8</ArticleId><ArticleId IdType="pmc">PMC8856880</ArticleId><ArticleId IdType="pubmed">35181867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lejal N., Truchet S., Bechor E., Bouguyon E., Khedkar V., Bertho N., Vidic J., Adenot P., Solier S., Pick E., et al. Turning off NADPH oxidase-2 by impeding p67phox activation in infected mouse macrophages reduced viral entry and inflammation. Biochim. et Biophys. Acta (BBA) Gen. Subj. 2018;1862:1263&#x2013;1275. doi: 10.1016/j.bbagen.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2018.03.004</ArticleId><ArticleId IdType="pubmed">29524539</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilly S., Romero M., Solier S., Feron O., Dessy C., Schwok A.S. Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor. Antioxidants. 2023;12:440. doi: 10.3390/antiox12020440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox12020440</ArticleId><ArticleId IdType="pmc">PMC9951936</ArticleId><ArticleId IdType="pubmed">36830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrier O.D.S., Pizzorno A., Henri J., Berenbaum F., Lina B., F&#xe8;ve B., Adnet F., Sabbah M., Rosa-Calatrava M., Mar&#xe9;chal V., et al. Broad-spectrum antiviral activity of naproxen: From Influenza A to SARS-CoV-2 Coronavirus. BioRxiv. 2020 doi: 10.1101/2020.04.30.069922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.30.069922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Tsai C.-H., Wang Y.-C., Yen L.-C., Chang Y.-W., Sun J.-R., Lin T.-Y., Chiu C.-H., Chao Y.-C., Chang F.-Y. SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19. Infection. 2023;52:955&#x2013;983. doi: 10.1007/s15010-023-02142-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02142-4</ArticleId><ArticleId IdType="pmc">PMC11143065</ArticleId><ArticleId IdType="pubmed">38133713</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Gao Y., Wen L., Zhai Z., Zhang S., Shan F., Feng J. Methionine enkephalin regulates microglia polarization and function. Int. Immunopharmacol. 2016;40:90&#x2013;97. doi: 10.1016/j.intimp.2016.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2016.08.037</ArticleId><ArticleId IdType="pubmed">27584058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W., Wang W., Liang L., Chen J., Sun S., Wei B., Zhong Y., Huang X.-R., Liu J., Wang X., et al. SARS-CoV-2 N protein induced acute kidney injury in diabetic db/db mice is associated with a Mincle-dependent M1 macrophage activation. Front. Immunol. 2023;14:1264447. doi: 10.3389/fimmu.2023.1264447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1264447</ArticleId><ArticleId IdType="pmc">PMC10655021</ArticleId><ArticleId IdType="pubmed">38022581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K.W., Linderman S.L., Moodie Z., Czartoski J., Lai L., Mantus G., Norwood C., Nyhoff L.E., Edara V.V., Floyd K., et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep. Med. 2021;2:100354. doi: 10.1016/j.xcrm.2021.100354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100354</ArticleId><ArticleId IdType="pmc">PMC8253687</ArticleId><ArticleId IdType="pubmed">34250512</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bert N., Tan A.T., Kunasegaran K., Tham C.Y.L., Hafezi M., Chia A., Chng M.H.Y., Lin M., Tan N., Linster M., et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584:457&#x2013;462. doi: 10.1038/s41586-020-2550-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2550-z</ArticleId><ArticleId IdType="pubmed">32668444</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following Mild SARS-CoV-2 Infection: Characteristic T Cell Alterations and Response to Antihistamines. J. Investig. Med. 2021;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Kempuraj D. Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID. Cells. 2023;12:688. doi: 10.3390/cells12050688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="pubmed">36899824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehboob R., Oehme P., Pfaff G. The role of Substance P in the defense line of the respiratory tract and neurological manifestations post COVID-19 infection. Front. Neurol. 2023;14:1052811. doi: 10.3389/fneur.2023.1052811.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1052811</ArticleId><ArticleId IdType="pmc">PMC10025330</ArticleId><ArticleId IdType="pubmed">36949854</ArticleId></ArticleIdList></Reference><Reference><Citation>Barde S., Aguila J., Zhong W., Solarz A., Mei I., Prud&#x2019;Homme J., Palkovits M., Turecki G., Mulder J., Uhl&#xe9;n M., et al. Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons. Eur. Neuropsychopharmacol. 2024;78:54&#x2013;63. doi: 10.1016/j.euroneuro.2023.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2023.09.004</ArticleId><ArticleId IdType="pubmed">37931511</ArticleId></ArticleIdList></Reference><Reference><Citation>Casello S.M., Flores R.J., Yarur H.E., Wang H., Awanyai M., Arenivar M.A., Jaime-Lara R.B., Bravo-Rivera H., Tejeda H.A. Neuropeptide System Regulation of Prefrontal Cortex Circuitry: Implications for Neuropsychiatric Disorders. Front. Neural Circuits. 2022;16:796443. doi: 10.3389/fncir.2022.796443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2022.796443</ArticleId><ArticleId IdType="pmc">PMC9255232</ArticleId><ArticleId IdType="pubmed">35800635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu D., Liu H., Zhu J., Xu H., Yao J. [D-Ala2, D-Leu5] Enkephalin Inhibits TLR4/NF-&#x3ba;B Signaling Pathway and Protects Rat Brains against Focal Ischemia-Reperfusion Injury. Mediat. Inflamm. 2021;2021:6661620. doi: 10.1155/2021/6661620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6661620</ArticleId><ArticleId IdType="pmc">PMC7895595</ArticleId><ArticleId IdType="pubmed">33628116</ArticleId></ArticleIdList></Reference><Reference><Citation>Papasidero I.D., Valli G., Marin D., Del Sasso A., De Magistris A., Cennamo E., Casalboni S., De Marco F., Rocchi R., Beumo B.N., et al. Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department. Medicina. 2022;58:1852. doi: 10.3390/medicina58121852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58121852</ArticleId><ArticleId IdType="pmc">PMC9782909</ArticleId><ArticleId IdType="pubmed">36557054</ArticleId></ArticleIdList></Reference><Reference><Citation>Podvin S., Jiang Z., Boyarko B., Rossitto L.-A., O&#x2019;donoghue A., Rissman R.A., Hook V. Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer&#x2019;s Disease Brain. ACS Chem. Neurosci. 2022;13:1992&#x2013;2005. doi: 10.1021/acschemneuro.2c00222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.2c00222</ArticleId><ArticleId IdType="pmc">PMC9264367</ArticleId><ArticleId IdType="pubmed">35758417</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Karson M.A., Tang A.-H., Milner T.A., Alger B.E. Synaptic Cross Talk between Perisomatic-Targeting Interneuron Classes Expressing Cholecystokinin and Parvalbumin in Hippocampus. J. Neurosci. 2009;29:4140&#x2013;4154. doi: 10.1523/JNEUROSCI.5264-08.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5264-08.2009</ArticleId><ArticleId IdType="pmc">PMC2853357</ArticleId><ArticleId IdType="pubmed">19339609</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar A.A.R., Yu T., O Demko Z., Hu C., Tornheim J.A., Blair P.W., Thomas D.L., Manabe Y.C. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection. Front. Immunol. 2023;14:1147549. doi: 10.3389/fimmu.2023.1147549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1147549</ArticleId><ArticleId IdType="pmc">PMC10176965</ArticleId><ArticleId IdType="pubmed">37187756</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1,284,437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMarino C., Lee M.-H., Cowen M., Steiner J.P., Inati S., Shah A.H., Zaghloul K.A., Nath A. Detection of SARS-CoV-2 Nucleocapsid and Microvascular Disease in the Brain. Neurology. 2023;100:624&#x2013;628. doi: 10.1212/WNL.0000000000201682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000201682</ArticleId><ArticleId IdType="pmc">PMC10065204</ArticleId><ArticleId IdType="pubmed">36526429</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Song W., Chan J.F.-W., Chen Y., Liu F., Ye Z., Lam A.H.-C., Cai J., Lee A.C.-Y., Wong B.H.-Y., et al. Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamsters. Emerg. Microbes Infect. 2023;12:2207678. doi: 10.1080/22221751.2023.2207678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2207678</ArticleId><ArticleId IdType="pmc">PMC10262819</ArticleId><ArticleId IdType="pubmed">37122119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehboob R., Lavezzi A.M. Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children&#x2014;A mystery so far. New insight into the role of Substance P. J. Neurol. Sci. 2020;420:117276. doi: 10.1016/j.jns.2020.117276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117276</ArticleId><ArticleId IdType="pmc">PMC7834711</ArticleId><ArticleId IdType="pubmed">33360484</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenberger L.M., Szabo S. A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection. Inflammopharmacology. 2022;30:1475&#x2013;1476. doi: 10.1007/s10787-022-01015-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-01015-w</ArticleId><ArticleId IdType="pmc">PMC9213171</ArticleId><ArticleId IdType="pubmed">35729443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuteit M., Baskal S., Klawitter S., Dopfer-Jablonka A., Behrens G.M.N., M&#xfc;ller F., Schr&#xf6;der D., Klawonn F., Steffens S., Tsikas D. Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects. Amino Acids. 2023;55:1173&#x2013;1188. doi: 10.1007/s00726-023-03305-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-023-03305-1</ArticleId><ArticleId IdType="pmc">PMC10564820</ArticleId><ArticleId IdType="pubmed">37516715</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrich T.J., Deeks S.G., Peluso M.J., Meyer N.J., Wherry E.J., Abramoff B.A., Cherry S., Thaiss C.A., Levy M., Wong A.C., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata A.F., Maley A.M., Wu C., Gilboa T., Norman M., Lazarovits R., Mao C.-P., Newton G., Chang M., Nguyen K., et al. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin. Chem. 2020;66:1562&#x2013;1572. doi: 10.1093/clinchem/hvaa213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa213</ArticleId><ArticleId IdType="pmc">PMC7499543</ArticleId><ArticleId IdType="pubmed">32897389</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Xiao F., Hu D., Ge W., Tian M., Wang W., Pan P., Wu K., Wu J. SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-&#x3b2; Production. Viruses. 2021;13:47. doi: 10.3390/v13010047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010047</ArticleId><ArticleId IdType="pmc">PMC7823417</ArticleId><ArticleId IdType="pubmed">33396605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu J., Xu J., Zhang L., Shu T., Wu D., Huang M., Ren Y., Li X., Geng Q., Xu Y., et al. SARS-CoV-2-encoded nucleocapsid protein acts as a viral suppressor of RNA interference in cells. Sci. China Life Sci. 2020;63:1413&#x2013;1416. doi: 10.1007/s11427-020-1692-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1692-1</ArticleId><ArticleId IdType="pmc">PMC7154568</ArticleId><ArticleId IdType="pubmed">32291557</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.J., Shin O.S. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response. Cells. 2021;10:530. doi: 10.3390/cells10030530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030530</ArticleId><ArticleId IdType="pmc">PMC7999926</ArticleId><ArticleId IdType="pubmed">33801464</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J., Tang W., Wang J., Lai D., Xu Q., Huang R., Hu Y., Gong X., Fan J., Shu Q., et al. SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-&#x138;B Activation. Front. Immunol. 2021;12:791753. doi: 10.3389/fimmu.2021.791753.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.791753</ArticleId><ArticleId IdType="pmc">PMC8688532</ArticleId><ArticleId IdType="pubmed">34950152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R.-C., Huang K., Zhang H.-P., Li L., Zhang Y.-F., Tan C., Chen H.-C., Jin M.-L., Wang X.-R. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J. Neuroinflamm. 2022;19:149. doi: 10.1186/s12974-022-02514-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02514-x</ArticleId><ArticleId IdType="pmc">PMC9198209</ArticleId><ArticleId IdType="pubmed">35705998</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M.-K., Han Y., Kim M.S., Seo E., Kang S., Park S.-Y., Koh H., Kim D.K., Lee H.-J. Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats. Korean J. Physiol. Pharmacol. 2012;16:181&#x2013;186. doi: 10.4196/kjpp.2012.16.3.181.</Citation><ArticleIdList><ArticleId IdType="doi">10.4196/kjpp.2012.16.3.181</ArticleId><ArticleId IdType="pmc">PMC3394920</ArticleId><ArticleId IdType="pubmed">22802699</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini M., Natoli S., Gardoni F., Di Luca M., Pisani A. Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19. Int. J. Mol. Sci. 2023;24:5618. doi: 10.3390/ijms24065618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065618</ArticleId><ArticleId IdType="pmc">PMC10056044</ArticleId><ArticleId IdType="pubmed">36982693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotoyama H., Namba H., Tohmi M., Nawa H. Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System. Biomolecules. 2023;13:372. doi: 10.3390/biom13020372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13020372</ArticleId><ArticleId IdType="pmc">PMC9953688</ArticleId><ArticleId IdType="pubmed">36830741</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirinzi T., Lattanzi R., Maftei D., Grillo P., Zenuni H., Boffa L., Albanese M., Simonetta C., Bovenzi R., Maurizi R., et al. Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction. Brain Behav. Immun. 2022;108:302&#x2013;308. doi: 10.1016/j.bbi.2022.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.12.017</ArticleId><ArticleId IdType="pmc">PMC9760596</ArticleId><ArticleId IdType="pubmed">36549578</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kelly B., Vidal L., McHugh T., Woo J., Avramovic G., Lambert J.S. Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study. Brain Behav. Immun. Health. 2022;24:100485. doi: 10.1016/j.bbih.2022.100485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100485</ArticleId><ArticleId IdType="pmc">PMC9250701</ArticleId><ArticleId IdType="pubmed">35814187</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall C., Lauterborn J., Burks D., Seroogy K. Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain. Brain Res. 1987;403:403&#x2013;408. doi: 10.1016/0006-8993(87)90085-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(87)90085-0</ArticleId><ArticleId IdType="pubmed">3548890</ArticleId></ArticleIdList></Reference><Reference><Citation>Loonam T.M., Noailles P.A., Yu J., Zhu J.P., A Angulo J. Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Life Sci. 2003;73:727&#x2013;739. doi: 10.1016/S0024-3205(03)00393-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(03)00393-X</ArticleId><ArticleId IdType="pubmed">12801594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalodia R., Antoine D., Braniff R.G., Dutta R.K., Ramakrishnan S., Roy S. Opioid-Use, COVID-19 Infection, and Their Neurological Implications. Front. Neurol. 2022;13:884216. doi: 10.3389/fneur.2022.884216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.884216</ArticleId><ArticleId IdType="pmc">PMC9169980</ArticleId><ArticleId IdType="pubmed">35677336</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder G., Castro D.C., Bruchas M.R., Scherrer G. Endogenous and Exogenous Opioids in Pain. Annu. Rev. Neurosci. 2018;41:453&#x2013;473. doi: 10.1146/annurev-neuro-080317-061522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-080317-061522</ArticleId><ArticleId IdType="pmc">PMC6428583</ArticleId><ArticleId IdType="pubmed">29852083</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Chen X., Zhang R., Kong L., Fang Y., Guo J., Shen B., Zhang L. Delta opioid peptide [D-ala2, D-leu5]-Enkephalin&#x2019;s ability to enhance mitophagy via TRPV4 to relieve ischemia/reperfusion injury in brain microvascular endothelial cells. Stroke Vasc. Neurol. 2024:svn-2023. doi: 10.1136/svn-2023-003080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2023-003080</ArticleId><ArticleId IdType="pubmed">38697767</ArticleId></ArticleIdList></Reference><Reference><Citation>Heles M., Mrozkova P., Sulcova D., Adamek P., Spicarova D., Palecek J. Chemokine CCL2 prevents opioid-induced inhibition of nociceptive synaptic transmission in spinal cord dorsal horn. J. Neuroinflamm. 2021;18:279. doi: 10.1186/s12974-021-02335-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02335-4</ArticleId><ArticleId IdType="pmc">PMC8638248</ArticleId><ArticleId IdType="pubmed">34857006</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemela V., Landtblom A., Nyholm D., Kneider M., Constantinescu R., Paucar M., Svenningsson P., Abujrais S., Burman J., Shevchenko G., et al. Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington&#x2019;s Disease. Mov. Disord. 2020;36:481&#x2013;491. doi: 10.1002/mds.28391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28391</ArticleId><ArticleId IdType="pmc">PMC7984171</ArticleId><ArticleId IdType="pubmed">33247616</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinoso-Arija R., L&#xf3;pez-Ram&#xed;rez C., Jimenez-Ruiz J.A., L&#xf3;pez-Campos J.L. Effectiveness of aprepitant in post-acute COVID19 syndrome. Clin. Case Rep. 2021;9:e04646. doi: 10.1002/ccr3.4646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.4646</ArticleId><ArticleId IdType="pmc">PMC8449093</ArticleId><ArticleId IdType="pubmed">34567551</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., Brenner M.J., De Luca P., Albanese M., D&#x2019;ascanio L., Ralli M., Roccamatisi D., Cingolani C., Vitelli F., Camaioni A., et al. Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study. Brain Sci. 2022;12:154. doi: 10.3390/brainsci12020154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12020154</ArticleId><ArticleId IdType="pmc">PMC8870047</ArticleId><ArticleId IdType="pubmed">35203918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Cai Z., Wang S., Zhang X., Qian J., Hong S., Li H., Wang M., Yang J., Yi Q. Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug&#x2013;induced apoptosis. Blood. 2009;114:3625&#x2013;3628. doi: 10.1182/blood-2009-05-220285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-05-220285</ArticleId><ArticleId IdType="pmc">PMC2766678</ArticleId><ArticleId IdType="pubmed">19710503</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas F.L., Fernandes G.G., Gutman E.G., De Lima E.V., Antonio L.S., Hammerle M.B., Mota-Araujo H.P., Colodeti L.C., Ara&#xfa;jo S.M., Froz G.M., et al. SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. 2023;42:112189. doi: 10.1016/j.celrep.2023.112189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B., Aleman S., Bach K., Boribong B.P., Buggert M., Cherry S., Chertow D.S., Davies H.E., Dupont C.L., et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nat. Immunol. 2023;24:1616&#x2013;1627. doi: 10.1038/s41590-023-01601-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Herskovitz J., Gendelman H.E. HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication. J. Neuroimmune Pharmacol. 2018;14:52&#x2013;67. doi: 10.1007/s11481-018-9785-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-018-9785-6</ArticleId><ArticleId IdType="pmc">PMC6501843</ArticleId><ArticleId IdType="pubmed">29572681</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa-Silva M.C., Lima M.N., Battaglini D., Robba C., Pelosi P., Rocco P.R.M., Maron-Gutierrez T. Infectious disease-associated encephalopathies. Crit. Care. 2021;25:236. doi: 10.1186/s13054-021-03659-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03659-6</ArticleId><ArticleId IdType="pmc">PMC8259088</ArticleId><ArticleId IdType="pubmed">34229735</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>